BiopharmaAsia

@Biopharma_asia

BioPharma Asia the premier source for unbiased, cutting edge editorial written the leading figures currently working in the global Pharma/Biopharma industry.

Vrijeme pridruživanja: lipanj 2012.

Tweetovi

Blokirali ste korisnika/cu @Biopharma_asia

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @Biopharma_asia

  1. Prikvačeni tweet
    9. kol 2019.

    LAST CHANCE TO BOOK YOUR FREE SEAT FOR TODAY’S WEBINAR ON HOW THE BPOG IS MAPPING FUTURE TECHNOLOGY NEEDS FOR REAL TIME RELEASE TESTING.

    Poništi
  2. High-Resolution Optical and Dielectric Methods Monitoring Cells in Bioprocesses -

    Poništi
  3. 4. velj
    Poništi
  4. 4. velj
    Poništi
  5. 4. velj
    Poništi
  6. 4. velj
    Poništi
  7. 4. velj
    Poništi
  8. 4. velj

    CONTINUOUS MANUFACTURING AS A DEFAULT PLATFORM FOR ORAL SOLID DRUG PRODUCTS Presented by Lawrence De Belder, Senior Principal Engineer Continuous Manufacturing at Johnson and Johnson And Bob Lenich, Director of Life Sciences Business at Emerson

    Poništi
  9. 4. velj

    SAMPLING DEVICES FOR IN-LINE NEAR INFRARED SPECTROSCOPY MONITORING OF POWDER BLEND HOMOGENEITY IN CONTINUOUS MANUFACTURING Anders Sparén, Principal Scientist at AstraZeneca Followed Powder Blend Homogeneity Monitoring with the Viavi MicroNIR PAT-W

    Poništi
  10. 4. velj

    CONTROL STRATEGY AND A REAL-TIME RELEASE TESTING FROM A DEVELOPMENT LINE TO COMMERCIAL MANUFACTURING PAT analysis performed on the core tablets by NIR spectroscopy to replace the final product testing Tom Van Den Kerkhof Scientist at Johnson & Johnson

    Poništi
  11. 4. velj

    THE JOURNEY OF IMPLEMENTING ADVANCED PROCESS CONTROL IN THE PHARMACEUTICAL INDUSTRY Presented by Olav Lyngberg, PhD, Sr. Scientific Fellow, Advanced Technology Center of Excellence, Technical Operations, Janssen Pharmaceuticals

    Poništi
  12. 4. velj

    AFFINITY CHROMATOGRAPHY FOR VACCINES PURIFICATION The journey of establishing the affinity purification platform focusing on main challenges and key results will be presented in the Webinar. Mikkel Nissum, Vaccine R&D Quality Site Lead at GSK Vaccines

    Poništi
  13. 4. velj

    QUANTIFICATION AND CONTROL OF AMORPHOUS CONTENTS BY RAMAN, APPLICATION AND CASE STUDIES IN PHARMACEUTICAL PROCESSING Michelle Raikes, M.S, Senior Scientist at Boehringer Ingelheim And Dr. Fredrik Nordstrom, Sr Research Fellow at Boehringer Ingelheim

    Poništi
  14. 4. velj

    ASSESSING THE RISK OF INTERACTION BETWEEN EXTRACTABLES AND LEACHABLE AND THERAPEUTIC PROTEINS Presented by Andrew Teasdale, Senior Principal Scientist Impurity management and External Advocacy at AstraZeneca

    Poništi
  15. 4. velj

    FULLY UTILIZING CLOSED SYSTEMS IN MODERN BIOPHARMA FACILITIES Presented by Lars Hovmand-Lyster, Senior Engineering Specialist in Novo Nordisk Global Project Office (GPO) Engineering Management Department

    Poništi
  16. 4. velj

    SINGLE-USE BIOPROCESS PLATFORM FOR VETERINARY VACCINE AND BIOPHARMACEUTICAL PILOT-SCALE PRODUCTION Identify the challenges of integrating vaccine and biopharmaceutical processes Francis Verhoeye, Global Pilot Operations Leader at Zoetis Inc.

    Poništi
  17. 3. velj

    FROM CONCEPT TO MARKET – UNIQUE APPROACHES IN BIOMANUFACTURING Presented by Dr. Jincai Li, Vice President of WuXi Biologics The presentation will also cover the continuous bioprocessing concept and share WuXi’s efforts on this area

    Poništi
  18. 3. velj

    NEXT FRONTIER IN SUBVISIBLE PARTICLE ANALYSIS: NEW TOOLS AND OPPORTUNITIES Danny Chou, President Compassion BioSolution, LLC Followed by an Industry Perspective presented by Mark Bumiller, Technology Manager at Particle Sizing Systems, an Entegris

    Poništi
  19. 3. velj

    STRATEGIES TO OVERCOME LOW ENDOTOXIN RECOVERY USING THE CONVENTIONAL LAL ASSAY Presented by Dr. Ruth Daniels, Senior Scientist – Microbiology Expert at Janssen And Kevin L. Williams, Microbiological Test Development at bioMérieux

    Poništi
  20. 3. velj

    GLOBAL STERILE TRANSPORTATION AND FORMULATION OF AN ADJUVANT Presented by Charlotte Masy, Project Manager in global support GSK vaccinés Presented by Donald Young, Sr. Product Manager at Thermo Fisher Scientific

    Poništi
  21. 3. velj

    ESTABLISHING EARLY DEVELOPMENT STRATEGIES FOR THERAPEUTIC PROTEINS Thorsten Lorenz, Head Early Drug Substance Development at Novartis And Sorina Morar-Mitrica, Principal Fellow Sr Drug Product Biologics at Novartis Renee Tobias, Director, Halo Labs

    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·